about
To count or not to count deaths: reranking effects in health distribution evaluation.Does HIV services decentralization protect against the risk of catastrophic health expenditures?: some lessons from Cameroon.Fairness in healthcare finance and delivery: what about Tunisia?Appraising financial protection in health: the case of Tunisia.Potential market size and impact of hepatitis C treatment in low- and middle-income countries.Medicine and democracy: The importance of institutional quality in the relationship between health expenditure and health outcomes in the MENA region.Equity in health care finance in Palestine: the triple effects revealed.How do supply-side factors influence informal payments for healthcare? The case of HIV patients in Cameroon.Individual and structural factors associated with HIV status disclosure to main partner in Cameroon: ANRS 12-116 EVAL survey, 2006-2007.Can a Circular Payment Card Format Effectively Elicit Preferences? Evidence From a Survey on a Mandatory Health Insurance Scheme in Tunisia.Catastrophic healthcare payments and impoverishment in the occupied Palestinian territory.Density of dental practitioners and access to dental care for the elderly: a multilevel analysis with a view on socio-economic inequality.Measuring and decomposing socioeconomic inequality in healthcare delivery: A microsimulation approach with application to the Palestinian conflict-affected fragile setting.Youth wellbeing through the lens of the Senian capability approach: insights from the occupied Palestinian territory: a cross-sectional study.Investigating the Dimensions of Youth Wellbeing: An Exploratory Structural Equation Modelling Approach Applied to PalestineHave health insurance reforms in Tunisia attained their intended objectives?Wealth, Health, and the Measurement of Multidimensional Inequality: Evidence from the Middle East and North AfricaEffect of development assistance on domestic health expendituresEquity in health care financing in Palestine: The value-added of the disaggregate approach
P50
Q30354985-539932DC-66C8-490E-9FC5-C8A584DA37EAQ36085431-03CEAC83-FE96-4F36-A833-0D18146F308BQ38858692-D3890FC8-8B13-4D84-B727-0BF97327F118Q38858697-CF8B5757-52A9-44CB-83DB-7A1ECBA45EE0Q38902281-AE422121-3CCF-45BB-B739-6ED6F5EAEF0BQ38917820-0A12D2B5-3649-4F56-8C0F-3C0CC51FA35DQ39907499-040D33BE-D74C-446F-90A4-F08DFA0D4A05Q43555809-27CC8BF1-16DB-4C1D-9357-A5032DC392D5Q44383353-E9ADCD77-A13E-48D2-8E1F-64A218B8B5D1Q46401792-8BE1ACE4-F6C9-41E4-9668-A33578A6A3E3Q50125546-171A616F-96D0-42A6-AF1F-F369F02F062CQ50168794-D93BF4B6-15C2-4757-9D22-D4C237C3DB37Q51626491-80309244-2E71-491E-AB6E-5D9B16354F93Q52382230-35033538-72A9-4FC3-AA07-36511D62856CQ56962286-2585FDC0-E592-4280-9236-0B785A6DD396Q56962294-559C0DDD-80B6-4402-B585-F0CF1CD60AB1Q56962303-DE301920-BF2D-45AF-8D3A-FC51C45CCA23Q56962313-571F2DFE-4356-4F40-80F9-143656E4BE48Q56962321-140B7E6E-561A-4EA6-B887-262264BDB61F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mohammad Abu-Zaineh
@ast
Mohammad Abu-Zaineh
@en
Mohammad Abu-Zaineh
@es
Mohammad Abu-Zaineh
@nl
Mohammad Abu-Zaineh
@sl
type
label
Mohammad Abu-Zaineh
@ast
Mohammad Abu-Zaineh
@en
Mohammad Abu-Zaineh
@es
Mohammad Abu-Zaineh
@nl
Mohammad Abu-Zaineh
@sl
altLabel
Mohammad ABU-ZAINEH
@en
prefLabel
Mohammad Abu-Zaineh
@ast
Mohammad Abu-Zaineh
@en
Mohammad Abu-Zaineh
@es
Mohammad Abu-Zaineh
@nl
Mohammad Abu-Zaineh
@sl
P1053
G-7121-2018
P106
P31
P3829
P496
0000-0001-8888-432X